David Buzas, MD
Sports Medicine · Neenah, WINPI 1588082846
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 56.2% of the total. Reporting peaked in 2019 at $12,316 and has fallen 95.4% since, to $561 in 2025.
Across 65 payments — averaging $273.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Stryker$3K
- ALON Medical Technology$2K
- Southern Edge Orthopaedics, Inc.$1K
- Smith+Nephew$504
- Johnson & Johnson$271
- plus $571 from 9 others
What the payments were for
- Grants$10,00056%
- Travel & lodging$8235%
- Food & beverage$3,74521%
- Education$3,22318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Stryker(2 entities) | 33 | $3,221 |
| ALON Medical Technology | 2 | $2,043 |
| Southern Edge Orthopaedics, Inc. | 1 | $1,180 |
| Smith+Nephew | 15 | $504 |
| Johnson & Johnson | 3 | $271 |
| Medtronic | 2 | $191 |
| Embody, Inc. | 1 | $120 |
| Mallinckrodt Hospital Products Inc. | 1 | $114 |
| Orthofix Medical, Inc. | 1 | $33 |
| Si-bone, Inc. | 1 | $32 |
| Vericel Corporation | 1 | $25 |
| Kerecis Limited | 1 | $22 |
| Organogenesis Inc. | 1 | $19 |
| Solventum Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,791 in reported general payments places this provider in the 85th percentile of 93 sports medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 275 | $944 |
| Methylprednisolone | 85 | $451 |
| Diclofenac Sodium | 39 | $303 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $284 |
| Celecoxib | 21 | $268 |
| Gabapentin | 35 | $190 |
| Ibuprofen | 11 | $74 |
| Cyclobenzaprine Hcl | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Neenah
- Erica KronckeNeenah$650
- Gregory CrovettiMount Pleasant$424K
- Andrea SpikerMadison$228K
- Brian GroganMadison$71K
- Jeffrey RossowWeston$69K
- Haley SmithMadison$65K
- Molly DayMadison$46K
- Eric CotterMadison$33K
- Jonathan StoneFranklin$20K
- Christopher DaleJanesville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.